Physiology and Pathophysiology of Estrogens: Lessons from Pediatric Patients with Complete Aromatase Deficiency

Endocrinologist

Volumn 14, Issue 2, 2004, Pages 93-100

  Belgorosky, Alicia ^a,b   Rivarola, Marco A ^a  

^a Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

^b Research Laboratory   (Argentina)

Author keywords

Ambiguous genitalia; Aromatase deficiency; Estrogens; Gonadotropins; Ovarian cysts

Indexed keywords

ANDROGEN; AROMATASE; CYTOCHROME P450; ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE;

AGE; ANDROGEN BLOOD LEVEL; BONE MATURATION; CHILD GROWTH; CHROMOSOME 15Q; CYP19 GENE; ENZYME ACTIVITY; ENZYME DEFICIENCY; EPIPHYSIS; ESTROGEN BLOOD LEVEL; FETUS DEVELOPMENT; FOLLITROPIN BLOOD LEVEL; GENDER; GENE; GENE MUTATION; GONADOTROPIN RELEASE; GROWTH ACCELERATION; GYNECOLOGIC DISEASE; HORMONAL REGULATION; HUMAN; INSULIN SENSITIVITY; KARYOTYPE 46,XX; LIPID METABOLISM; LOW DRUG DOSE; LUTEINIZING HORMONE BLOOD LEVEL; OVARY CYST; PATHOGENESIS; PATHOPHYSIOLOGY; PLACENTA; PUBERTY; REVIEW; RISK; SEX DIFFERENCE; SEX DIFFERENTIATION; VIRILIZATION;

EID: 1842535925     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000123567.27319.e2     Document Type: Review

References (21)

1. Means GD, Mahendroo MS, Corbin JC, et al. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem. 1989;264:19385-19391.
2. Graham-Lorence S, Amarneh B, White RE, et al. A three-dimensional model of aromatase cytochrome P450. Protein Sci. 1995;4:1065-1080.
3. Siiteri PK, MacDonald PC. The utilization of circulating dehydroepiandrosterone sulfate for estrogen synthesis during human pregnancy. Steroids. 1963;2:713-730.
4. Pepe GJ, Albrecht ED. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev. 1995;16:608-648.
5. Harada N, Ogawa H, Shozu M, et al. Biochemical and molecular genetic analyses on placental aromatase (P.450 arom) deficiency. J Biol Chem. 1992;267:4781-4785.
6. Conte FA, Grumbach MM, Ito Y, et al. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab. 1994;78:1287-1292.
7. Morishima A, Grumbach MM, Simpson ER, et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 1995;80:3689-3698.
8. Portrat-Doyen S, Forest MG, Nicolino M, et al. Female pseudohermaphroditism (FPH) resulting from aromatase (P450arom) deficiency associated with a novel mutation (R457) in the CYP19 gene. Horm Res. 1996;46(suppl):14.
9. Mullis PE, Yoshimura N, Kuhlmann B, et al. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab. 1997;82:1739-1745.
10. Carani C, Quin K, Simoni M, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med. 1997;337:91-95.
11. Ludwig M, Beck A, Wickert L, et al. Female pseudohermaphroditism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene. J Pediatr Endocrinol Metab. 1998;11:657-664.
12. Deladoëy J, Flück C, Bex M, et al. Aromatase deficiency caused by a novel P450arom gene mutation: Impact of absent estrogen production on serum gonadotropin concentration in a boy. J Clin Endocrinol Metab. 1999;84:4050-4054.
13. Hermann BL, Saller B, Janssen OE, et al. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in theCYP19 gene. J Clin Endocrinol Metab. 2002;87:5476-5484.
14. Belgorosky A, Pepe C, Marino R, et al. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase deficient girl who is a compound heterozygote for two new point mutations of the CYP19 gene. J Clin Endocrinol Metab. 2003 (in press).
15. Berensztein E, Sciara M, Rivarola MA, et al. Apoptosis and Proliferation of human testicular somatic and germ cells during prepuberty: high rate of testicular growth in newborns mediated by decreased apoptosis. J Clin Endocrinol Metabol. 2002;87:5113-5118.
16. Belgorosky A. Rivarola MA. Irreversible increase of serum IGF-1 and IGFBP-3 levels in central precocious puberty of different etiologies. Implications for the onset of puberty. Horm Res. 1998;49:226-232.
17. Robertson KM, O'Donnell L, Jones ME, et al. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp19) gene. Proc Natl Acad Sci U S A. 1999;96:7986-7991.
18. Eddy EM, Washburn TF, Bunch DO, et al. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology. 1996;137:4796-4805.
19. Britt KL, Drummond AE, Cox VA, et al. An age-related ovarian phenotype in mice with targeted disruption of the CYP19 (aromatase) gene. Endocrinology. 2000;141:2614-2623.
20. Weil S, Vendola K, Zhou J, et al. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab. 1999;84:2951-2956.
21. Turner RT, Riggs BL, Spelsberg TC. Skeletal effects of estrogen. Endocr Rev. 1994;15:275-300.